Also in this playlist...
This transcript is automatically generated
It's not now speaking the earnings she measuring a busy day -- -- spirits up that is are already US Bancorp.
Is out better -- expected dead but also we're gonna have as the day goes on your out of -- -- right.
Let's talk about some of the three big -- we're going to be looking at first Coca-Cola have a Coke and a smile investors have been smiling over cook for awhile our expectations or 87 cents earnings per share revenue of ten point eight billion.
Fourth quarter results for Coca-Cola really well eleven billion dollars in the fourth quarter as far as revenue.
And they had earnings per shares -- nine cents they were beaten and be back in the fourth quarter and this time around.
-- looking to see how they're offsetting higher commodity costs as well as the cost cutting program they've instituted look for growth in emerging markets.
As both the fact that look these guys sell one point seven billion servings of Coke products daily worldwide not -- Also watching Johnson & Johnson -- per share expectation from the street -- dollar and 35 cents.
On revenue sixteen point two billion want to see how the impact they lost the patent rights.
To two drugs last year -- they antibiotic level Quinn as well as the ADHD medications -- Wanna see that so have any kind of impact.
Again expecting revenue of sixteen point 22 billion then Goldman Sachs.
You think is gonna be any kind of impact from that -- salesman who wrote that letter to the editorial department at the New York Times well.
We'll find out Goldman Sachs expected to come in we of that earnings per share of -- three dollars 55 cents on revenue of nine point four billion both sides Citi.
As well as JPMorgan have shown strong increase is on they're trading desks.
Wanna see if Goldman who's supposed to be the champion at this stuff to be come look at this yet they do against JPMorgan back to you guys Adams so as those numbers come out -- -- back to out of here of the.
Filter by section